AI assistant
Sending…
Annovis Bio, Inc. — Director's Dealing 2021
Oct 13, 2021
34695_dirs_2021-10-13_2f4e1fb0-dda9-4d2c-8d19-0153625915ab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Annovis Bio, Inc. (ANVS)
CIK: 0001477845
Period of Report: 2021-10-11
Reporting Person: Bruck Claudine (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-11 | Common Stock | P | 181 | $27.66 | Acquired | 6067 | Direct |
More from Annovis Bio, Inc.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Feb 12
Regulatory Filings
2026
Jan 28
Director's Dealing
2025
Dec 8